Sigilon Therapeutics' Incubator/Accelerator Round

Sigilon Therapeutics raised a round of funding on February 01, 2018. Investors include The Hive.

Sigilon Therapeutics discovers and develops category-defining biocompatible encapsulated cell therapies. Sigilon Therapeutics' discovery platform combines cell engineering and biocompatible Afibromer …

Articles about Sigilon Therapeutics' Incubator/Accelerator Round: